scispace - formally typeset
Journal ArticleDOI

Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions.

Reads0
Chats0
TLDR
An international group of experts were convened to standardize definitions of New‐Onset Refractory Status Epilepticus (NORSE), Febrile Infection‐Related Epilepsy Syndrome (FIRES), and related conditions to enable improved communication for investigators, physicians, families, patients, and other caregivers.
Abstract
We convened an international group of experts to standardize definitions of New-Onset Refractory Status Epilepticus (NORSE), Febrile Infection-Related Epilepsy Syndrome (FIRES), and related conditions. This was done to enable improved communication for investigators, physicians, families, patients, and other caregivers. Consensus definitions were achieved via email messages, phone calls, an in-person consensus conference, and collaborative manuscript preparation. Panel members were from 8 countries and included adult and pediatric experts in epilepsy, electroencephalography (EEG), and neurocritical care. The proposed consensus definitions are as follows: NORSE is a clinical presentation, not a specific diagnosis, in a patient without active epilepsy or other preexisting relevant neurological disorder, with new onset of refractory status epilepticus without a clear acute or active structural, toxic or metabolic cause. FIRES is a subcategory of NORSE, applicable for all ages, that requires a prior febrile infection starting between 2 weeks and 24 hours prior to onset of refractory status epilepticus, with or without fever at onset of status epilepticus. Proposed consensus definitions are also provided for Infantile Hemiconvulsion-Hemiplegia and Epilepsy syndrome (IHHE) and for prolonged, refractory and super-refractory status epilepticus. This document has been endorsed by the Critical Care EEG Monitoring Research Consortium. We hope these consensus definitions will promote improved communication, permit multicenter research, and ultimately improve understanding and treatment of these conditions.

read more

Citations
More filters
Journal ArticleDOI

Anakinra Therapy for Non-cancer Inflammatory Diseases.

TL;DR: Anakinra has an unparalleled record of safety: opportunistic infections, particularly Mycobacterium tuberculosis, are rare even in populations at risk for reactivation of latent infections.
Journal ArticleDOI

International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions

TL;DR: The childhood onset epilepsy syndromes are described, most of which have both mandatory seizure type(s) and interictal electroencephalographic (EEG) features, highlighting the mandatory seizure(s), EEG features, phenotypic variations, and findings from key investigations.
Journal ArticleDOI

Tocilizumab treatment for new onset refractory status epilepticus.

TL;DR: Investigation of the therapeutic potential of the interleukin‐6 receptor inhibitor tocilizumab in patients with new onset refractory status epilepticus found no recurrence of SE, however, 2 patients experienced severe adverse events related to infection during the tocilIZumab therapy.
Journal ArticleDOI

Febrile seizures: an overview.

TL;DR: Continuous preventative antiepileptic therapy for the prevention of recurrent febrile seizures is not recommended and the use of intermittent anticonvulsant therapy is not routinely indicated.
References
More filters
Related Papers (5)